In vitro characterization of immune-related properties of human fetal bone cells for potential tissue engineering applications

Tissue Engineering - Part A

Volumn 15, Issue 7, 2009, Pages 1523-1532

  Montjovent, Marc Olivier ^a   Bocelli Tyndall, Chiara ^b   Scaletta, Corinne ^c   Scherberich, Arnaud ^b   Mark, Silke ^d   Martin, Ivan ^b   Applegate, Lee Ann ^c   Pioletti, Dominique P ^a  

^a EPFL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

APPLICATIONS; BONE; CELL CULTURE; CELL MEMBRANES; FLOW CYTOMETRY; FLOWCHARTING; GENE EXPRESSION; INTERFERONS; TISSUE ENGINEERING;

ALKALINE PHOSPHATASE; ALLOGENEIC CELLS; ANTIPROLIFERATIVE EFFECT; BEFORE AND AFTER; BONE CELLS; BONE METABOLISM; BONE TISSUE-ENGINEERING; CYTOKINES; GENE EXPRESSION LEVELS; HUMAN LEUKOCYTE ANTIGEN; IMMUNE RECOGNITION; IMMUNOLOGICAL PROPERTIES; IN-VITRO; MESENCHYMAL STEM CELL; PERIPHERAL BLOOD MONONUCLEAR CELLS; RECOMBINANT HUMAN INTERFERON; STEM CELL; SURFACE MARKERS; TISSUE ENGINEERING APPLICATIONS;

OSTEOBLASTS;

ALKALINE PHOSPHATASE; B7 ANTIGEN; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; HERMES ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTERCELLULAR ADHESION MOLECULE 1; MEMBRANE ANTIGEN; STRO 1 PROTEIN; UNCLASSIFIED DRUG;

ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIGEN RECOGNITION; ARTICLE; BONE CELL; BONE METABOLISM; CELL ACTIVATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; FETUS; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGENICITY; IMMUNOMODULATION; IN VITRO STUDY; MESENCHYMAL STEM CELL; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; TISSUE ENGINEERING;

EID: 67650682757     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2008.0222     Document Type: Article

References (70)

1. Connolly, J. F. Injectable bone marrow preparations to stimulate osteogenic repair. Clin Orthop Relat Res 8, 1995.
2. Quarto, R., Mastrogiacomo M., Cancedda R., Kutepov S. M., Mukhachev V., Lavroukov A., Kon E., and Marcacci M. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 344, 385, 2001.
3. Krebsbach, P. H., Mankani M. H., Satomura K., Kuznetsov S. A., and Robey P. G. Repair of craniotomy defects using bone marrow stromal cells. Transplantation 66, 1272, 1998.
4. Dragoo, J. L., Lieberman J. R., Lee R. S., Deugarte D. A., Lee Y., Zuk P. A., Hedrick M. H., and Benhaim P. Tissueengineered bone from BMP-2-transduced stem cells derived from human fat. Plast Reconstr Surg 115, 1665, 2005.
5. Winn, S. R., Schmitt J. M., Buck D., Hu Y., Grainger D., and Hollinger J. O. Tissue-engineered bone biomimetic to regenerate calvarial critical-sized defects in athymic rats. J Biomed Mater Res 45, 414, 1999.
6. Muschler, G. F., Nitto H., Matsukura Y., Boehm C., Valdevit A., Kambic H., Davros W., Powell K., and Easley K. Spine fusion using cell matrix composites enriched in bone marrow-derived cells. Clin Orthop Relat Res 102, 2003.
7. Ponticiello, M. S., Schinagl R. M., Kadiyala S., and Barry F. P. Gelatin-based resorbable sponge as a carrier matrix for human mesenchymal stem cells in cartilage regeneration therapy. J Biomed Mater Res 52, 246, 2000.
8. Yan, H., and Yu C. Repair of full-thickness cartilage defects with cells of different origin in a rabbit model. Arthroscopy 23, 178, 2007.
9. Young, R. G., Butler D. L., Weber W., Caplan A. I., Gordon S. L., and Fink D. J. Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res 16,406, 1998.
10. Bertram, H., Mayer H., and Schliephake H. Effect of donor characteristics, technique of harvesting and in vitro processing on culturing of human marrow stroma cells for tissue engineered growth of bone. Clin Oral Implants Res 16, 524, 2005.
11. Muschler, G. F., Nitto H., Boehm C. A., and Easley K. A. Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J Orthop Res 19, 117, 2001.
12. Muschler, G. F., Boehm C., and Easley K. Aspiration to obtain osteoblast progenitor cells from human bone marrow: the influence of aspiration volume. J Bone Joint Surg Am 79,1699, 1997.
13. Pittenger, M. F., Mackay A. M., Beck S. C., Jaiswal R. K., Douglas R., Mosca J. D., Moorman M. A., Simonetti D. W., Craig S., and Marshak D. R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
14. Inoue, K., Ohgushi H., Yoshikawa T., Okumura M., Sempuku T., Tamai S., and Dohi Y. The effect of aging on bone formation in porous hydroxyapatite: biochemical and histological analysis. J Bone Miner Res 12, 989, 1997.
15. Le Blanc, K., and Ringden O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11,321, 2005.
16. Nauta, A. J., Westerhuis G., Kruisselbrink A. B., Lurvink E. G., Willemze R., and Fibbe W. E. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood 108, 2114, 2006.
17. Le Blanc, K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 5, 485, 2003.
18. Lee, J. Y., Qu-Petersen Z., Cao B., Kimura S., Jankowski R., Cummins J., Usas A., Gates C., Robbins P., Wernig A., and Huard J. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol 150, 1085, 2000.
19. Bosch, P., Musgrave D. S., Lee J. Y., Cummins J., Shuler T., Ghivizzani T. C., Evans T., Robbins T. D., and Huard. Osteoprogenitor cells within skeletal muscle. J Orthop Res 18,933, 2000.
20. Zuk, P. A., Zhu M., Mizuno H., Huang J., Futrell J. W., Katz A. J., Benhaim P., Lorenz H. P., and Hedrick M. H. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7, 211, 2001.
21. Winn, S. R., Randolph G., Uludag H., Wong S. C., Hair G. A., and Hollinger J. O. Establishing an immortalized human osteoprecursor cell line: OPC1. J Bone Miner Res 14, 1721, 1999.
22. Montjovent, M. O., Burri N., Mark S., Federici E., Scaletta C., Zambelli P. Y., Hohlfeld P., Leyvraz P. F., Applegate L. L., and Pioletti D. P. Fetal bone cells for tissue engineering. Bone 35, 1323, 2004.
23. Montjovent, M. O., Mark S., Mathieu L., Scaletta C., Scherberich A., Delabarde C., Zambelli P. Y., Bourban P. E., Applegate L. A., and Pioletti D. P. Human fetal bone cells associated with ceramic reinforced PLA scaffolds for tissue engineering. Bone 42, 554, 2008.
24. Frank, O., Heim M., Jakob M., Barbero A., Schafer D., Bendik I., Dick W., Heberer M., and Martin I. Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro. J Cell Biochem 85, 737, 2002.
25. Bocelli-Tyndall, C., Bracci L., Spagnoli G., Braccini A., Bouchenaki M., Ceredig R., Pistoia V., Martin I., and Tyndall A. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro. Rheumatology (Oxford) 46, 403, 2007.
26. Livak, K. J., and Schmittgen T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402, 2001.
27. Gronthos, S., Zannettino A. C., Graves S. E., Ohta S., Hay S. J., and Simmons P. J. Differential cell surface expression of the STRO-1 and alkaline phosphatase antigens on discrete developmental stages in primary cultures of human bone cells. J Bone Miner Res 14, 47, 1999.
28. Indig, F. E., Benayahu D., Fried A., Wientroub S., and Blumberg S. Neutral endopeptidase (EC 3.4.24.11) is highly expressed on osteoblastic cells and other marrow stromal cell types. Biochem Biophys Res Commun 172, 620, 1990.
29. Reyes-Botella, C., Montes M. J., Vallecillo-Capilla M. F., Olivares E. G., and Ruiz C. Antigenic phenotype of cultured human osteoblast-like cells. Cell Physiol Biochem 12, 359, 2002.
30. Reyes-Botella, C., Montes M. J., Vallecillo-Capilla M. F., Olivares E. G., and Ruiz C. Expression of molecules involved in antigen presentation and T cell activation (HLA-DR, CD80, CD86, CD44 and CD54) by cultured human osteoblasts. J Periodontol 71, 614, 2000.
31. Reyes-Botella, C., Montes M. J., Abadia-Molina A. C., Vallecillo-Capilla M. F., and Ruiz C. CD10 expression in cultured human osteoblast-like cells. Folia Biol (Praha) 45,257, 1999.
32. Garcia-Martinez, O., Reyes-Botella C., Aguilera-Castillo O., Vallecillo-Capilla M. F., and Ruiz C. Antigenic profile of osteoblasts present in human bone tissue sections. Biosci Rep 26, 39, 2006.
33. Aruffo, A., Stamenkovic I., Melnick M., Underhill C. B., and Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 61, 1303, 1990.
34. Carter, W. G., and Wayner E. A. Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. J Biol Chem 263, 4193, 1988.
35. Nakamura, H., Kenmotsu S., Sakai H., and Ozawa H. Localization of CD44, the hyaluronate receptor, on the plasma membrane of osteocytes and osteoclasts in rat tibiae. Cell Tissue Res 280, 225, 1995.
36. Jamal, H. H., and Aubin J. E. CD44 expression in fetal rat bone: in vivo and in vitro analysis. Exp Cell Res 223, 467, 1996.
37. Tanaka, Y., Morimoto I., Nakano Y., Okada Y., Hirota S., Nomura S., Nakamura T., and Eto S. Osteoblasts are regulated by the cellular adhesion through ICAM-1 and VCAM-1. J Bone Miner Res 10, 1462, 1995.
38. Tanaka, Y., Nakayamada S., and Okada Y. Osteoblasts and osteoclasts in bone remodeling and inflammation. Curr Drug Targets Inflamm Allergy 4, 325, 2005.
39. Fujii, Y., Fujii K., Nakano K., and Tanaka Y. Crosslinking of CD44 on human osteoblastic cells upregulates ICAM-1 and VCAM-1. FEBS Lett 539, 45, 2003.
40. Roebuck, K. A., and Finnegan A. Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J Leukoc Biol 66, 876, 1999.
41. Jahnke, A., and Johnson J. P. Intercellular adhesion molecule 1 (ICAM-1) is synergistically activated by TNF-alpha and IFN-gamma responsive sites. Immunobiology 193, 305, 1995.
42. de Wit, H., Dokter W. H., Koopmans S. B., Lummen C., van der Leij M., Smit J. W., and Vellenga E. Regulation of p100 (NFKB2) expression in human monocytes in response to inflammatory mediators and lymphokines. Leukemia 12,363, 1998.
43. Grey, H. M., Kubo R. T., Colon S. M., Poulik M. D., Cresswell P., Springer T., Turner M., and Strominger J. L. The small subunit of HL-A antigens is beta 2-microglobulin. J Exp Med 138, 1608, 1973.
44. Johansen, J. S., Williamson M. K., Rice J. S., and Price P. A. Identification of proteins secreted by human osteoblastic cells in culture. J Bone Miner Res 7, 501, 1992.
45. Evans, D. B., Thavarajah M., and Kanis J. A. Immunoreactivity and proliferative actions of beta 2 microglobulin on human bone-derived cells in vitro. Biochem Biophys Res Commun 175, 795, 1991.
46. Balint, E., and Sprague S. M. Beta(2)-microglobulin and bone cell metabolism. Nephrol Dial Transplant 16, 1108, 2001.
47. Krampera, M., Cosmi L., Angeli R., Pasini A., Liotta F., Andreini A., Santarlasci V., Mazzinghi B., Pizzolo G., Vinante F., Romagnani P., Maggi E., Romagnani S., and Annunziato F. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24, 386, 2006.
48. Gotherstrom, C., Ringden O., Tammik C., Zetterberg E., Westgren M., and Le Blanc K. Immunologic properties of human fetal mesenchymal stem cells. Am J Obstet Gynecol 190, 239, 2004.
49. Chen, X. L., Chen P., Jia Z. Q., Liu Y. N., Ma K. T., Zhang Y. Z., and Zhou C. Y. [HLA expression in human fetal bone marrow mesenchymal stem cells]. Beijing Da Xue Xue Bao 38, 597, 2006.
50. Natali, P. G., Russo C., and Ng A.-K. Tissue distribution of human Ia-like antigens. In: S. Ferrone and C. S. David, eds. Ia Antigens. Boca Raton, FL: CRC Press, 1982, p. 81-110.
51. Ozato, K., Wan Y. J., and Orrison B. M. Mouse major histocompatibility class I gene expression begins at midsomite stage and is inducible in earlier-stage embryos by interferon. Proc Natl Acad Sci U S A 82, 2427, 1985.
52. Majumdar, M. K., Keane-Moore M., Buyaner D., Hardy W. B., Moorman M. A., McIntosh K. R., and Mosca J. D. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci 10, 228, 2003.
53. Skjodt, H., Hughes D. E., Dobson P. R., and Russell R. G. Constitutive and inducible expression of HLA class II determinants by human osteoblast-like cells in vitro. J Clin Invest 85, 1421, 1990.
54. Geppert, T. D., and Lipsky P. E. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression. J Immunol 135, 3750, 1985.
55. Amento, E. P., Bhan A. K., McCullagh K. G., and Krane S. M. Influences of gamma interferon on synovial fibroblast-like cells. Ia induction and inhibition of collagen synthesis. J Clin Invest 76, 837, 1985.
56. Jahn, B., Burmester G. R., Schmid H., Weseloh G., Rohwer P., and Kalden J. R. Changes in cell surface antigen expression on human articular chondrocytes induced by gammainterferon. Induction of Ia antigens. Arthritis Rheum 30, 64, 1987.
57. Stanley, K. T., VanDort C., Motyl C., Endres J., and Fox D. A. Immunocompetent properties of human osteoblasts: interactions with T lymphocytes. J Bone Miner Res 21, 29, 2006.
58. Klyushnenkova, E., Mosca J. D., Zernetkina V., Majumdar M. K., Beggs K. J., Simonetti D. W., Deans R. J., and McIntosh K. R. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J Biomed Sci 12, 47, 2005.
59. Di Nicola, M., Carlo-Stella C., Magni M., Milanesi M., Longoni P. D., Matteucci P., Grisanti S., and Gianni A. M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99, 3838, 2002.
60. Hauschka, P. V., Mavrakos A. E., Iafrati M. D., Doleman S. E., and Klagsbrun M. Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose. J Biol Chem 261, 12665, 1986.
61. Seyedin, S. M., Thomas T. C., Thompson A. Y., Rosen D. M., and Piez K. A. Purification and characterization of two cartilage-inducing factors from bovine demineralized bone. Proc Natl Acad Sci U S A 82, 2267, 1985.
62. Robey, P. G., Young M. F., Flanders K. C., Roche N. S., Kondaiah P., Reddi A. H., Termine J. D., Sporn M. B., and Roberts A. B. Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro. J Cell Biol 105, 457, 1987.
63. Deckers, M. M., van Bezooijen R. L., van der Horst G., Hoogendam J., van Der Bent C., Papapoulos S. E., and Lowik C. W. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 143, 1545, 2002.
64. Deckers, M. M., Karperien M., van der Bent C., Yamashita T., Papapoulos S. E., and Lowik C. W. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 141, 1667, 2000.
65. von Schroeder, H. P., Veillette C. J., Payandeh J., Qureshi A., and Heersche J. N. Endothelin-1 promotes osteoprogenitor proliferation and differentiation in fetal rat calvarial cell cultures. Bone 33, 673, 2003.
66. Dodds, R. A., Merry K., Littlewood A., and Gowen M. Expression of mRNA for IL1 beta, IL6 and TGF beta 1 in developing human bone and cartilage. J Histochem Cytochem 42, 733, 1994.
67. Littlewood, A. J., Russell J., Harvey G. R., Hughes D. E., Russell R. G., and Gowen M. The modulation of the expression of IL-6 and its receptor in human osteoblasts in vitro. Endocrinology 129, 1513, 1991.
68. Chaudhary, L. R., Spelsberg T. C., and Riggs B. L. Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1 beta and tumor necrosis factor-alpha: lack of regulation by 17 beta-estradiol. Endocrinology 130, 2528, 1992.
69. Volejnikova, S., Laskari M., Marks S. C., Jr., and Graves D. T. Monocyte recruitment and expression of monocyte chemoattractant protein-1 are developmentally regulated in remodeling bone in the mouse. Am J Pathol 150, 1711, 1997.
70. Quintin, A., Hirt-Buri N., Scaletta C., Schizas C., and Pioletti D.P. Consistency of fetal cell banks for research and clinical use. Cell Transplantation 16, 675, 2007.